Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Antibiotics and cardiac risk: A look at recent data, a call for increased awareness Erik Swain
-
- A paradigm shift in HF management William Abraham, MD
- FDA advisory panel recommends approval of edoxaban for prevention of stroke, systemic embolism
- FDA approves contact force-sensing ablation catheter
- Everest expedition provides clues about BP at high altitudes
- AF may double risk for silent cerebral infarction
- AHA/ASA: Diet, exercise, BP control key for primary prevention of stroke
- Amiodarone use increased stroke, systemic embolism risk in patients with AF
- Angina symptoms linked with elevated risk for CV events in patients with stable CAD
-
- Consensus statement published on appropriate use of left ventriculography
- Hand-held ultrasound more accurate than physical exam for diagnosing CV abnormalities
- Implementing AHA guidelines reduced non-ICU telemetry use, saved costs
- Inappropriate use of cardiac stress tests with imaging linked to excess costs, harm
- Low-molecular-weight heparin more cost-effective than unfractionated heparin for VTE prevention
- PFO closure may be cost-effective in long term
- Platelet activation linked to MI in patients with pneumonia
- Telemonitoring reduced readmissions, costs in patients with HF
-
- Study of EES in women, minority patients underway
- 3-D nitinol stent maintained primary patency at 2 years
- AMBITION: Combination therapy reduced risk for clinical failure in patients with PAH
- CANOPY: Carotid artery stenting safe, effective in standard-risk patients in a real-world setting
- Cholesterol efflux capacity inversely associated with CV events
- DAPT: Longer-duration therapy decreased stent thrombosis and MACCE, increased bleeding
- DCB shows promise in femoropopliteal arterial disease, diabetes
- Despite perceived differences, international hypertension guidelines 'mostly similar'
-
- Genetic predisposition to elevated LDL tied to aortic valve calcium, aortic stenosis
- INHERIT: Losartan did not improve left ventricular mass in patients with hypertrophic cardiomyopathy
- ISAR-SAFE: Net clinical outcomes no different for 6-month, 12-month DAPT after PCI
- ITALIC: Outcomes comparable for 6 vs. 24 months of DAPT after PCI
- Losartan, atenolol demonstrate similar efficacy, safety in Marfan syndrome
- MagnaSafe: MRI safe for patients with pacemakers, ICDs
- New trials underway to explore impact of anti-inflammatory therapy on CV events
- Novel oral anticoagulants vs. warfarin: The debate continues
-
- ODYSSEY ALTERNATIVE: Alirocumab superior to ezetimibe for LDL lowering in statin-intolerant patients
- Peripheral paclitaxel-eluting stent showed superior patency, clinical benefit at 5 years
- Trial Scorecard: AFFORD
- Trial Scorecard: CANOPY
- Trial Scorecard: DKCRUSH-VI
- Trial Scorecard: DURABILITY Iliac
- Trial Scorecard: Mimics
- Trial Scorecard: RAISE-ETP
-
- Trial Scorecard: RECORD-AF
- Trial Scorecard: VELOCITY